- Whole Saliva Collection Devices
- Glandular Saliva Collection Devices
The saliva collection devices market is estimated to be valued at USD 263.3 million in 2021 at a CAGR of 12.9% over the forecast years (2022-2028). Increased approvals for saliva collection devices are expected to drive growth in the saliva collection devices market due to the growing need for rapid diagnosis of life-threatening diseases. Furthermore, technological advancements in infant saliva collection are expected to drive the growth of the saliva collection devices market. For example, Oasis Diagnostics created the Pedia SAL collection kit for infants. It enables saliva collection with the simplest design, with the goal of not only collecting saliva samples but also relaxing infants during the procedure. As the number of ailments increases, so will the number of clinical trials conducted by the government, creating new opportunities for the growth of the saliva collection devices market. The opportunity for point of care test kits is increasing due to mandating of drug abuse testing for employees, drivers, and person working at hazardous jobs. Development and launch of point-of-care test kits may enhance the revenue of market over the forecast timeframe. For instance, in January 2019, Alere received FDA 510(k) clearance of two new drug screening tests offer practitioner rapid, in-office results for the most abused opioid-derived drugs using urine sample. In the saliva collection devices market, the biotech companies segment expected to contribute the highest revenue share of 67.8% in 2021. The biotech companies' rapid advancements and innovative technologies may boost the market. Key Developments: In Jan 2020, Salimetrics Introduced a New Salivary Human Total Immunoglobulin G (IgG) ELISA Kit to Aid Multidisciplinary Serological Researchers. The launch of this Salimetrics Salivary IgG Assay Kit is the result of extensive collaboration with public health researchers. In Sept 2020, QIAGEN acquired NeuMoDx Molecular, Inc. The NeuMoDx systems full integration will enable QIAGEN to meet laboratory needs for molecular diagnostics in practically any situation.
Fastest Growing Market
The prevalent rapid advancement occurring in healthcare, particularly in diagnostics and the emergence of new medical procedures and experimentations, are mainly responsible for leading the global saliva collection devices market. The high costs of setting up equipment required for carrying out quality and ethical saliva collection, as well as a lack of necessary expertise to carry out such activities in underdeveloped regions, are major impediments to the saliva collection devices market.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.